SEC Filing Details
Document Details
Form
Filing Date
Apr 4, 2018
Document Date
Sep 6, 2017
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Myovant Sciences Ltd.
Issuer
Myovant Sciences Ltd.
Filer
Dexcel Pharma Technologies Ltd.